In the DURATION-8 study, the SGLT2i dapagliflozin was used in combination therapy with exenatide and showed reductions in HbA1c, systolic blood pressure, and blood glucose, with improved weight loss, when compared to monotherapy [93]
This multifaceted mechanism makes GLP-1 a powerful hormone for regulating blood sugar, managing weight, and maintaining overall metabolic health
And where many online guides give you dangerously incomplete information
En los pacientes que han tenido carcinoma medular de tiroides o en la familia, la dulaglutida, la liraglutida, la semaglutida y la tirzepatida, un agonista dual del receptor de GLP-1/GIP, estn contraindicadas
& Majumdar, S